Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
4.670
-0.090 (-1.89%)
At close: Aug 10, 2026, 4:00 PM EDT
4.580
-0.090 (-1.93%)
After-hours: Aug 10, 2026, 7:34 PM EDT
Treace Medical Concepts Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Treace Medical Concepts stock has a consensus rating of "Hold" and an average price target of $5.50. The average 1-year stock price forecast is 17.77% higher than the current stock price, while the lowest is $4.50 (-3.64%) and the highest is $7.00 (+49.89%).
Price Target: $5.50 (+17.77%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Treace Medical Concepts stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 3 | 3 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Hold Reiterates $4 → $5 | Hold | Reiterates | $4 → $5 | +7.07% | Aug 10, 2026 |
| Lake Street | Lake Street | Buy Reiterates $7 | Buy | Reiterates | $7 | +49.89% | Aug 10, 2026 |
| UBS | UBS | Hold Maintains $2.5 → $2.25 | Hold | Maintains | $2.5 → $2.25 | -51.82% | Mar 2, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $3 | Hold | Maintains | $3 | -35.76% | Mar 2, 2026 |
Financial Forecast
Revenue This Year
207.39M
from 212.69M
Decreased by -2.49%
Revenue Next Year
221.61M
from 207.39M
Increased by 6.86%
EPS This Year
-0.91
from -0.80
EPS Next Year
-0.85
from -0.91
EPS and Forward PE are based on non-GAAP adjusted numbers.